the total revenues of 5,249 MTHB of which 5,216 MTHB earned from sales revenues. Sales revenues increased by 440 MTHB or 9.2% comparing to the same period of the year 2017. Such increase was mainly from
impairment loss from the liquidation of Solvay Biochemicals (Taixing) Limited (“SBT”) were fully booked in 2017. * Note Please find further information in the consolidated financial statements. 2 Summary of
Company and its subsidiaries recorded the total revenues of 4,581 MTHB of which 4,557 MTHB earned from sales revenues. Sales revenues increased by 621 MTHB or 15.8% comparing to the same period of the year
the total revenues of 4,810 MTHB of which 4,776 MTHB earned from sales revenues. Sales revenues increased by 1,389 MTHB or 41.0% comparing to the same period of the year 2016, mainly from higher selling
unitholders as well as to do all other acts as may be necessary for the completion of liquidation in accordance with the rules, conditions and procedures as specified in the notification of the SEC. The
million Baht in 2020, and net loss of 156.50 million Baht in 2019. The Company’s net profit has increased by 645.01 million Baht or 412.16 % from the previous year. In 2020, the Company realized the after
announcement of biodiesel mandatory changed from B7 to B10. However, the average biodiesel selling price is significantly increased, which tracked the Crude Palm Oil (CPO) price in 2021 (Source: DIT) was 38.00